Acelyrin Inc [SLRN] stock is trading at $6.40, up 1.91%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SLRN shares have gain 1.59% over the last week, with a monthly amount glided 29.82%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Acelyrin Inc [NASDAQ: SLRN] stock has seen the most recent analyst activity on August 14, 2024, when H.C. Wainwright downgraded its rating to a Neutral and also revised its price target to $6 from $18. Previously, Wells Fargo upgraded its rating to Overweight on July 08, 2024, and kept the price target unchanged to $13. On December 13, 2023, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $11 on the stock. Citigroup started tracking the stock assigning a Neutral rating and suggested a price target of $8 on December 08, 2023. Morgan Stanley downgraded its rating to a Equal-Weight but $19 remained the price target by the analyst firm on September 13, 2023. H.C. Wainwright started tracking with a Buy rating for this stock on September 05, 2023, and assigned it a price target of $44. In a note dated May 30, 2023, TD Cowen initiated an Outperform rating.
Acelyrin Inc [SLRN] stock has fluctuated between $3.36 and $10.50 over the past year. Currently, Wall Street analysts expect the stock to reach $10.5 within the next 12 months. Acelyrin Inc [NASDAQ: SLRN] shares were valued at $6.40 at the most recent close of the market. An investor can expect a potential return of 64.06% based on the average SLRN price forecast.
Analyzing the SLRN fundamentals
Gross Profit Margin for this corporation currently stands at -0.56% with Operating Profit Margin at -2261.05%, Pretax Profit Margin comes in at -1806.01%, and Net Profit Margin reading is -1806.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.46, Equity is -0.81 and Total Capital is -0.66. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.27 points at the first support level, and at 6.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.48, and for the 2nd resistance point, it is at 6.55.
Ratios To Look Out For
For context, Acelyrin Inc’s Current Ratio is 7.86. In addition, the Quick Ratio stands at 7.86 and the Cash Ratio stands at 1.55.
Transactions by insiders
Recent insider trading involved Becker Daniel J., Director, that happened on Jul 17 ’24 when 1.0 shares were sold. Chief Executive Officer, Lin Shao-Lee completed a deal on Apr 01 ’24 to sell 9961.0 shares. Meanwhile, Chief Executive Officer Lin Shao-Lee sold 15701.0 shares on Feb 20 ’24.
